A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: Introducing a novel modality, ttfields

Seminars in Oncology

Volumn 40, Issue 6, 2013, Pages

  Butowski, Nicholas ^a   Wong, Eric T ^b   Mehta, Minesh P ^c   Wilson, Lydia K ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; ETOPOSIDE; HYDROXYUREA; IMATINIB; IRINOTECAN; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

CANCER PATIENT; COMPUTER SYSTEM; CONFERENCE PAPER; CONSTIPATION; CORTICOSTEROID THERAPY; DERMATITIS; DIARRHEA; FATIGUE; GLIOBLASTOMA; HUMAN; LYMPHOCYTOPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION INJURY; SKIN IRRITATION; STEREOTACTIC BIOPSY; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 84890389697     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2013.10.002     Document Type: Conference Paper

References (15)

1. E.C. Holland Glioblastoma multiforme: The terminator Proc Natl Acad Sci U S A 97 2000 6242 6244
2. Gutin PH, Wong ET. Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality. ASCO. Chicago, IL; June 1 - 5, 2012
3. P.Y. Wen, and S. Kesari Malignant gliomas in adults N Engl J Med 359 5 2008 492 507
4. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 2005 987 996
5. Central nervous system cancers. NCCN Guidelines Version 2.2013.
6. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant Temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
7. M.C. Chamberlain Bevacizumab for the treatment of recurrent glioblastoma Clin Med Insights Oncol 5 2011 117 129
8. A.D. Norden, G.S. Young, and K. Setayesh Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence Neurology 70 1 2008 779 787
9. E. Fonkem, and E.T. Wong NovoTTF-100A: a new treatment modality for recurrent glioblastoma Expert Rev Neurother 12 8 2012 895 899
10. Y. Palti Management of recurrent or progressive glioblastoma multiforme with low-intensity, medium-frequency alternating electric fields Eur Oncol Dis 2007 88 89
11. E.D. Kirson, Z. Gurvich, and R. Schneiderman Disruption of cancer cell replication by alternating electric fields Cancer Res 64 9 2004 3288 3295
12. Instructions for Use. NovoTTF-100A system. Novocure. Issue date: May 12, 2013.
13. E.D. Kirson, V. Dbaly, and F. Tovarys Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors Proc Natl Acad Sci U S A 104 24 2007 10152 10157
14. E.D. Kirson, R.S. Schneiderman, and V. Dbaly Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields) BMC Med Phys 9 1 2009
15. R. Stupp, E.T. Wong, and A.A. Kanner NovoTTF-100A versus physicians' choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality Eur J Cancer 48 14 2012 2192 2202